Taysha Gene Therapies Inc (NASDAQ:TSHA) currently has a daily average trading volume of 2.85M but it saw 22169095 shares traded in last market. With a market cap of 590.31M USD, the company’s current market price of $2.75 came rising about 12.70 while comparing to the previous closing price of $2.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.32 and as low as $1.05.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BMO Capital Markets which initiated the stock as “Outperform” in its note to investors issued on June 27, 2024, recommending a price target of $5 for it. Jefferies issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $14 and $1.50.
Over the week, TSHA’s stock price is moving -4.84% down while it is 51.10% when we observe its performance for the past one month. Year-to-date it is 58.96% up and over the past year, the stock is showing a downside performance of -15.12%.
Currently, Taysha Gene Therapies Inc’s total number of outstanding shares is 205.05M with 17.15% of that held by the insiders while 78.90% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -75.53% and return on equity (ROE) at -159.34%. Stock’s beta reads 0.95. Stock has a price to book (P/B) ratio of 10.24 while price to sale or P/S ratio amounts to 81.76. Its return on asset (ROA) is -59.56% on average.
